
Loading, please wait...

Loading, please wait...

Sorting biocolloids like exosomes and DNA at the molecular level is essential for modern diagnostics. However, nanoscale nanoparticle sorting using Deterministic Lateral Displacement (DLD) has faced significant hurdles due to Brownian motion. While DLD works effectively at the microscale, reducing the scale to nanometers allows diffusion to blur the deterministic trajectories required for precise separation.
A groundbreaking numerical study has introduced a two-dimensional finite-element model to tackle these challenges. Researchers found that diffusion exerts its strongest influence near zero-velocity points within the microfluidic channel. This effect causes particles to shift from a displacement mode to a zigzag mode, creating an "uncertainty region." Consequently, achieving reliable separation requires a precise understanding of these transitions.
Furthermore, the researchers introduced the concept of "zero-crossing time" for velocity. This metric serves as a dynamic measure of how much Brownian influence affects a particle. By setting a threshold for this growth, the study successfully mapped the boundaries of the uncertainty region. Therefore, designers can now create DLD systems with greater predictability. Moreover, these findings provide a robust framework for developing the next generation of liquid biopsy technologies.
Additionally, researchers now emphasize that designers must adapt traditional DLD models for the nanoscale to maintain resolution. Consequently, engineers must balance the interplay between fluid dynamics and stochastic forces. As a result, this study provides clear guidelines for sorting particles down to 20 nanometers. This advancement is particularly vital for identifying early-stage cancer markers in blood or urine.
Nanoscale sorting allows for the precise isolation of biocolloids such as exosomes, viruses, and circulating tumor DNA. These particles are critical for non-invasive "liquid biopsies," which help in the early detection and monitoring of diseases like cancer.
At the nanoscale, Brownian motion (diffusion) becomes dominant. It causes particles to deviate from their intended paths, leading to a mix of zigzag and displacement modes. This blurring reduces the separation resolution and makes it difficult to isolate specific particle sizes reliably.
The zero-crossing time acts as a quantitative indicator of Brownian influence. It helps researchers determine where the uncertainty region begins and ends. Using this data, engineers can optimize pillar arrangements to ensure particles follow deterministic paths despite diffusion.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional clinical judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A numerical study introduces a new method to quantify diffusion effects in nanoscale DLD, enhancing precision in sorting biocolloids like exosomes and DNA....
7 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today